Autophagy is the major intracellular degradation pathway that regulates long-lived proteins and organelles turnover. This process occurs at basal levels in all cells but it is rapidly upregulated in response to starvation and cellular stress. Although being recently implicated in neurodegeneration, it remains still unclear whether autophagy has a detrimental or protective role. In this study, we investigated the dynamics of the autophagic process in retinal tissue that has undergone transient ischemia, an experimental model that recapitulates features of ocular pathologies, including glaucoma, anterior ischemic optic neuropathy and retinal vessels occlusion. Retinal ischemia, induced in adult rats by increasing the intraocular pressure, was characterized by a reduction in the phosphatidylethanolamine-modified form of LC3 (LC3II) and by a significant decrease in Beclin-1. The latter event was associated with a proteolytic cleavage of Beclin-1, leading to the accumulation of a 50-kDa fragment. This event was prevented by intravitreal treatment with the non-competitive N-methyl-D-aspartate antagonist MK801 and calpain inhibitors or by calpain knockdown. Blockade of autophagy by pharmacological inhibition or Beclin-1 silencing in RGC-5 increased cell death, suggesting a pro-survival role of the autophagic process in this neuronal cell type. Altogether, our results provide original evidence for calpain-mediated cleavage of Beclin-1 and deregulation of basal autophagy in the rat retina that has undergone ocular ischemia/reperfusion injury. Autophagy is an evolutionarily conserved process by which eukaryotic cells regulate the turnover of long-lived proteins and cytoplasmic organelles. Depending on mechanisms and functions, three types of autophagy have been described in mammalians: macroautophagy, microautophagy and chaperone-mediated autophagy.
, G Bagetta 1, 4 and MT Corasaniti 2 Autophagy is the major intracellular degradation pathway that regulates long-lived proteins and organelles turnover. This process occurs at basal levels in all cells but it is rapidly upregulated in response to starvation and cellular stress. Although being recently implicated in neurodegeneration, it remains still unclear whether autophagy has a detrimental or protective role. In this study, we investigated the dynamics of the autophagic process in retinal tissue that has undergone transient ischemia, an experimental model that recapitulates features of ocular pathologies, including glaucoma, anterior ischemic optic neuropathy and retinal vessels occlusion. Retinal ischemia, induced in adult rats by increasing the intraocular pressure, was characterized by a reduction in the phosphatidylethanolamine-modified form of LC3 (LC3II) and by a significant decrease in Beclin-1. The latter event was associated with a proteolytic cleavage of Beclin-1, leading to the accumulation of a 50-kDa fragment. This event was prevented by intravitreal treatment with the non-competitive N-methyl-D-aspartate antagonist MK801 and calpain inhibitors or by calpain knockdown. Blockade of autophagy by pharmacological inhibition or Beclin-1 silencing in RGC-5 increased cell death, suggesting a pro-survival role of the autophagic process in this neuronal cell type. Altogether, our results provide original evidence for calpain-mediated cleavage of Beclin-1 and deregulation of basal autophagy in the rat retina that has undergone ocular ischemia/reperfusion injury. Autophagy is an evolutionarily conserved process by which eukaryotic cells regulate the turnover of long-lived proteins and cytoplasmic organelles. Depending on mechanisms and functions, three types of autophagy have been described in mammalians: macroautophagy, microautophagy and chaperone-mediated autophagy. 1 Macroautophagy (hereafter referred to as autophagy) is the most prevalent form and involves the formation of the autophagosome. This is a double-membrane structure that, following engulfment of cytoplasmic components such as proteins, lipid and damaged organelles, docks and fuses with the lysosomal compartment to form the autolysosome. Here, the content of the autophagosome is degraded by the lysosomal hydrolases and recycled for macromolecular synthesis and ATP generation.
Autophagy occurs at low basal levels in virtually all cells performing homeostatic function, and acts as a catabolic adaptive process in response to different forms of stress, including starvation, growth factor withdrawal, high bioenergetic demands, hypoxia, endoplasmic reticulum stress or accumulation of protein aggregates. 2 Besides its participation in neuronal homeostasis, 3 development and remodeling, 4, 5 autophagy has recently drawn increasing attention for its role in neuronal cell death associated with chronic neurodegenerative disorders and acute neuronal injury. 6 Dysfunctions in the autophagic process have been linked to Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease, as well as to brain hypoxia/ischemia or trauma. 7 Retinal ischemia is a common clinical condition representing the main cause of visual impairment and blindness. 8 Ischemic phenomena occur in a variety of ocular pathologies, including anterior ischemic optic neuropathy, retinal and choroidal vessel occlusion, diabetic retinopathy, traumatic optic neuropathy and glaucoma. 8, 9 Common hallmark for these conditions is the progressive degeneration and the final loss of the retinal ganglion cells (RGCs) that through the optic nerve fibers transmit the visual information to the central areas of the visual pathway. Block of blood flow to the retina triggers a self-reinforcing detrimental cascade involving neuronal depolarization, calcium overload, oxidative stress and alteration of glutamate homeostasis.
In turn, the disruption of glutamate homeostasis leads to excitotoxic neuronal damage through the overactivation of Nmethyl-D-aspartate (NMDA) and non-NMDA glutamate receptors. 10, 11 At cellular level, transient retinal ischemia results in extensive neuronal cell death characterized by an early phase of necrosis and a prolonged phase of apoptosis. 12 Aim of this study was to investigate the dynamics of the autophagic process in the retina by using both an in vivo model of ocular ischemia induced by the transient elevation of the intraocular pressure (IOP) and RGCs exposed to serum withdrawal. Our results showed that autophagy deregulation occurs during retinal ischemia. This was associated with Beclin-1 cleavage mediated by calpains and dependent on NMDA receptor activation. Furthermore, Beclin-1 silencing reduced RGC viability under starvation, thus suggesting a pro-survival role for autophagy in this experimental context.
Results
Beclin-1 localizes mainly in the ganglion cell layer of the intact retina. Beclin-1 is part of a class III phosphatidylinositol-3-kinase (PI3K) complex that participates in the early steps of the autophagic vesicles formation, and it is essential for the recruitment of other Atg proteins to the preautophagosomal structure. 13 Beclin-1 distribution in the retina was investigated by immunofluorescence. In intact retinas, Beclin-1 immunoreactivity was diffused throughout all retina layers, with a higher expression in the inner segment and particularly in the ganglion cell layer (GCL) as shown in Figure 1a . To identify the type of cell expressing Beclin-1, double-labeling experiments with RGC and Mü ller cell markers were performed. In the GCL, Beclin-1 immunoreactivity partially colocalized with the cytosolic and dendritic compartments of TUJ1-labeled RGCs and with the glial fibrillary acidic protein (GFAP)-positive Mü ller cell processes and end-feet-surrounding RGCs as shown in Figures 1b and c. Beclin-I and LC3II levels decrease under retinal ischemia-reperfusion. LC3I is a cytosolic protein whose lipidated form, LC3II (phosphatidylethanolamine-modified form of LC3), is stably associated to the autophagosomal membrane and is therefore considered an autophagyspecific marker.
14 To determine whether an ischemic insult can modulate autophagy in the retina, we monitored the expression of LC3 and Beclin-1 by western blot in rat retinas that have undergone high IOP.
Compared with the contralateral, non-ischemic eye, LC3II levels were significantly reduced in the ischemic retina between 0 and 1 h of reperfusion ( Figure 2a ) and returned to basal levels after 24 h of reperfusion; no significant changes of the LC3 cytosolic form (LC3I) were detected over the analyzed time points (Figure 2a) .
The LC3II reduction was associated with a significant decrease of Beclin-1 in the post-ischemic phase. Following ischemia, Beclin-1 expression was below the constitutive level during the first 24 h of reperfusion, showing a more pronounced and significant decrease after 1 h of reperfusion (Figure 2b ). In the retina subjected to ischemia, Beclin-1 was After 7 days from the ischemic insult, the ischemic retinas showed Beclin-1 and LC3II levels comparable to the basal levels of non-ischemic retinas (Figure 2c ).
Beclin-1 undergoes proteolytic cleavage following retinal ischemia-reperfusion. In retinas that have undergone high IOP, Beclin-1 reduction was accompanied by the appearance of an additional band reactive to the antiBeclin-1 antibody and characterized by a molecular weight of 50 kDa (Figure 2d ). This fragment accumulated during the first hour of reperfusion and then slowly decreased over the 24 h (Figure 2d ), paralleling Beclin-1 reduction and thus suggesting that cleavage of the full-length protein had occurred.
Retinal ischemia leads to calpain activation. Previous work from our and other groups showed the contribution of excitotoxicity to neurodegeneration induced by ischemia in the retina. 11, 15 Overactivation of glutamate receptors, mainly the NMDA subtypes, results in calcium overload and consequent activation of calcium-dependent enzymes. 16 Together with the caspase cascade, also activation of the calcium-dependent cysteine proteases, calpains, occurs in excitotoxicity and represents an early step in the sequence of events leading to neuronal death.
To investigate activation of calpains in our model, we monitored the formation of a-spectrin breakdown products (SBDPs) by western blot. In contrast to caspase-3, generating a 150-kDa and an apoptotic-specific 120-kDa fragment, calpains cleave non-erythroid a-spectrin into two breakdown products of 150 and 145 kDa. 17 The appearance of the typical 150/145-kDa doublet was observed after 50 min of ischemia (reperfusion time 0), indicating a significant calpain activation (Figures 3a and b) . Calpain activation further increased during the first hour of reperfusion and was maintained at 6 and 24 h of reperfusion (Figures 3a and b) , showing a temporal profile overlapping the appearance of the Beclin-1 fragment (Figure 2d ). No significant modulation of the caspase-3-mediated 120-kDa SBDP was detected at the same time points (Figures 3a and b) . At 24 h after ischemia, an additional fragment of 105 kDa was detectable in all samples, suggesting a further proteolytic cleavage of the substrate (Figure 3a ).
Beclin-1 cleavage is dependent on calpain activity and NMDA receptor activation. To identify the temporal Intravitreal administration of the use-dependent, noncompetitive NMDA receptor antagonist MK801 (50 nmol, given 5 min before ischemia and at the beginning of the reperfusion) abolished calpain activation, as shown by the reduction of the 150/145-kDa fragments (Figure 3c ). The same treatment also reduced the accumulation of the 50-kDa Beclin-1 fragment at 1 h of reperfusion (Figure 3d) .
To further correlate Beclin-1 cleavage to activation of calpains, the effect of the two calpain inhibitors MDL28170 (calpain inhibitor III) and SJA6017 was studied.
As expected, intravitreal injection of the calpain inhibitors (1 mM, 3 ml/eye, given intravitreally 5 min before ischemia induction and at the beginning of reperfusion) blocked calpain activity at 1 h of reperfusion, as shown by the absence of the typical 150/145-kDa fragments (Figure 4 ). Pharmacological inhibition of calpains was paralleled by a significant reduction in the formation of the Beclin-1 fragment and by the increase of the full-length protein at 1 h of reperfusion (Figure 4) .
Finally, knockdown of both m-and m-calpain isoforms was performed by using a calpain small-subunit 1 small interfering RNA (CAPNS1 siRNA).
Effectiveness of silencing was checked by monitoring the appearance of the 150/145-kDa calpain-mediated SBDP in retinas subjected to ischemia and reperfused for 1 h (Figure 5a) . A substantial reduction in a-spectrin proteolysis was detected in the retinas of rats receiving the intravitreal injection of siRNA (10 mg/eye, 48 h before ischemia) when compared with the vehicle and the non-targeting scramble siRNA-treated animals (Figure 5a) .
Silencing of CAPNS1 completely prevented the appearance of the 50-kDa Beclin-1 fragment typically observed in the ischemic retinas after 1 h of reperfusion (Figure 5b) , thus confirming that, in our experimental setting, calpains were responsible for Beclin-1 cleavage.
Autophagy promotes RGC-5 survival. Depending on the context, autophagy has been shown to have either prosurvival or pro-death functions. To test the role of autophagy on RGCs survival, we induced autophagy in RGC-5 cells by serum starvation 18 and assayed cell viability. Cells starved for 24 h showed a significant increase of Beclin-1 and LC3II levels ( Figure 6a ) and an altered intracellular localization of LC3, as revealed by immunofluorescence (Figure 6b ). Cells grown in nutrient-rich medium (10% serum; CTR) showed a diffused LC3 cytoplasmic distribution, whereas cells that have undergone serum deprivation (SD) showed intense dot-like LC3-positive structures, indicating the localization of LC3II on autophagic membranes and the increase of autophagosome formation (Figure 6b) .
Serum starvation significantly reduced RGC-5 cell viability (Figure 6c) . To determine the effects of autophagy inhibition on cell survival, cells were treated with two autophagy inhibitors: bafilomycin A1 (BafA1), which increases intravesicular pH and therefore inhibits autophagy completion, 19 and 3-methyladenine (3-MA), a nucleotide derivative that blocks class III PI3K activity 20 upstream of LC3II formation. Treatment of RGC-5 with BafA1 (100 nM 18 ) for 24 h strongly increased the accumulation of the lipidated form of LC3 and significantly reduced cell viability under starvation (46 versus 69% of serum-starved cells; Po0.05; Figures 6d and e) . A similar effect on cell survival was obtained when the cells were exposed to 3-MA (10 mM 18 ) during the 24 h of SD (16 versus 69% of serum-starved cells; Po0.05; Figure 6e ).
Beclin-1 silencing reduces RGC-5 viability under starvation. To investigate the effects of Beclin-1 reduction on RGC survival, cells were transfected with rat Beclin-1-siRNA 48 h before SD. Gene silencing reduced Beclin-1 expression by 95% compared with starved scrambletransfected cells as shown by western blotting analysis (Figure 7a ) and led to a reduction of LC3II formation under starvation (Figure 7a ) similar to the pattern observed in vivo (Figure 2 ). Beclin-1 silencing significantly worsened the reduction of RGC-5 viability, as assessed by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, after 24 h of starvation (36 versus 67% of serum-starved cells; Po0.05; Figure 7b ).
Discussion
Depending on the circumstances, autophagy can have both beneficial and detrimental effects on neurons. Blocking of Figure 4 Beclin-1 cleavage depends on calpain activation. Representative western blotting showing the effect of calpain inhibitors MDL28179 and SJA6017 on calpain activation and Beclin-1 cleavage at 1 h of reperfusion. Calpain inhibition by intravitreal treatment with MDL28170 or SJA6017 completely prevented the accumulation of the 150/145-kDa SBDP, and significantly reduced Beclin-1 cleavage as shown by the reduction of the 50-kDa band corresponding to Beclin-1 fragment and the recovery of the 60-kDa full-length protein band. Control animals were subjected to intravitreal injection of the vehicle corresponding to the treatment (DMSO 10%). Densitometric analyses of the autoradiographic bands, normalized to the value of the loading control, are reported in the histograms. Values are the mean ± S.E.M. of three independent experiments. *Po0.05, **Po0.01 versus vehicle. L, left eye; MW, molecular weight; R, right ischemic eye Figure 5 Beclin-1 proteolytic cleavage is abrogated by calpain knockdown. (a) Effectiveness of calpain small-subunit (CAPNS1) silencing. In vivo knockdown of calpains by intravitreal injection of a specific CAPNS-siRNA was verified by the abrogation of the calpain proteolytic activity on a-spectrin in animals subjected to 50 min of ischemia, followed by 1 h of reperfusion. Western blotting analysis showed no changes of calpain proteolytic activity in the retinas from animals treated with the scramble non-targeting (NT) siRNA. Densitometric analysis of the 150/145-kDa SBDP bands showed a reduction by 87% in the CAPNS1 siRNA-treated animals (CAPNS1-siRNA ¼ 0.13±0.11 versus vehicle ¼ 1±0.02). (b) Beclin-1 cleavage was completely abrogated in the CAPNS1-silenced retinas subjected to ischemia, as shown by the absence of the 50-kDa proteolytic fragment and the recovery of the full-length protein observed at 1 h of reperfusion. Histograms show the densitometric analysis of the autoradiographic bands. Each value is the mean±S.E.M. of three independent experiments. ***Po0.001 versus vehicle and NT siRNA. L, left eye; MW, molecular weight; R, right ischemic eye autophagy causes neurodegeneration, 3, 4 and alterations of the autophagy pathway have been observed in chronic neurodegenerative conditions, including AD, 21 PD 22 and Huntington's disease. 23 Autophagy is also activated in neuronal cells exposed to hypoxic, 24 excitotoxic 25 or ischemic injuries. 26 Retinal ischemia is a common clinical condition and a relevant cause of visual impairment and blindness. Ocular ischemia induced by transient elevation of IOP in rat is a common animal model used to investigate the mechanisms underlying retinal neuronal death. With this method, a global ischemia is produced by the obstruction of both retinal and uveal circulation, leading to pathological features similar to those observed after central retinal artery occlusion and acute angle-closure glaucoma. 8 We investigated the participation of autophagy in the neurodegenerative processes accompanying ischemia in the retina following IOP and observed a decrease in LC3II, the autophagosomal associated form of LC3. This was accompanied by Beclin-1 reduction during the reperfusion phase and was indicative of a general deregulation of the retinal autophagic machinery following ischemia/ reperfusion. Although Beclin-1 appeared to be expressed throughout all retinal layers, higher immunoreactivity was detected in the RGCs, suggesting a prevalence of the autophagic process in this neuronal type.
In our model, Beclin-1 reduction was associated with the appearance of a 50-kDa fragment in the ischemic retinas during the first hour of reperfusion, suggesting the occurrence of a proteolytic cleavage. Caspases 3, 7 and 8 have recently been reported to cleave Beclin-1, producing two proteolytic fragments of 35 and/or 37 kDa. 27, 28 However, the late time of caspase activation following ischemia in the retina (12 h after reperfusion 29 ), as well as the different molecular weights of the fragments seemed to exclude the involvement of this cascade in this cleavage. Therefore, we investigated the role of the major alternative degradation pathway of calpains, whose activation has been reported after ocular hypertension in rat 30 as well as in primate retinas during hypoxia. 31 Calpain inhibition by MDL28170 and SJA6017, as well as calpains silencing by siRNA prevented the formation of the fragment, thus indicating the contribution of these enzymes to Beclin-1 cleavage in our model. Calpain-mediated cleavage of Beclin-1 was previously reported in recombinant assay in vitro 32 and in cultured hepatocytes exposed to anoxia/reoxygenation. 18, 33 However, to the best of our knowledge, our data represent the first evidence of Beclin-1 cleavage in neuronal tissue and the first report of Beclin-1 as a substrate of calpains in vivo.
Calpains are calcium-dependent enzymes activated by intracellular Ca 2 þ increase consequent to glutamate receptors overactivation and associated with excitotoxicity. The latter contributes to a variety of acute and chronic neurodegenerative diseases and has a key role also in RGC death associated with retinal ischemia. 10 However, the relation between autophagy and excitotoxic cell death is still controversial. NMDA treatment of organotypic hippocampal slices, as well as striatal injection of kainic acid, is associated with induction of autophagy. In these same models, inhibition of autophagosomal formation prevented neuronal death, 25, 34 linking excitotoxicity to induction of autophagy via a common Ca 2 þ -mediated pathway. In contrast, recent studies identified inhibitors of intracellular Ca 2 þ currents as activators of autophagy. 35, 36 In agreement with the latter observation, our data would support a Ca 2 þ -mediated inhibition of autophagy via the calpain-mediated Beclin-1 cleavage and provide a possible link between excitotoxicity and the impaired autophagy often observed in neurodegenerative diseases.
NMDA receptor antagonists and calpain inhibitors have been shown to reduce neurodegeneration triggered by ischemia in the retina. 11, 30 Thus, the calpain inhibitor SJA6017 reduced cell loss in the GCL after retinal ischemia-reperfusion; 30 furthermore, neuroprotection by calpain inhibition has been also reported in an acute ocular hypertension/ischemia model 37 and following NMDA-induced retinal damage. 38 Our data suggest that prevention of Beclin-1 cleavage and autophagy deregulation might be implicated in the neuroprotection afforded by NMDA receptor antagonists and calpain inhibitors in retinal ischemia-reperfusion injury.
To date, very little is known on the role of the autophagic pathway in RGC death. Activation of autophagy was observed in RGC following optic nerve transection, and a protective role was suggested for this process in RGC-5 cells under starvation. 18 A persistent accumulation of autophagosomes, concurring to the injury-induced axonal degradation and secondary to the lesion-induced calcium influx, was reported in the optic nerve following optic nerve crush. 39 In our study, Beclin-1 knockdown in starved RGC-5 prevented LC3II formation, thereby the induction of autophagy, and increased the cell death rate. This result, in accordance with previous work, 18 points toward a neuroprotective role of autophagy in RGC exposed to detrimental stimuli.
In summary, our findings provide evidence of the autophagy impairment in the ischemic retina, support a neuroprotective role of autophagy in RGCs and suggest that excitotoxicity negatively regulates autophagy through the calpain-mediated cleavage of Beclin-1.
In recent years, the connection between autophagy and neurodegeneration has been strengthened by several studies highlighting the vulnerability of neurons to stress-related signals that impair the autophagic process. Our study suggests that alterations of the autophagic pathway might be an important aspect in retinal pathologies associated with ischemic events and, therefore, a potential target for new and supporting therapeutic interventions.
Materials and Methods
Retinal ischemia injury. Male Wistar rats (280-330 g) were purchased from Charles River (Lecco, Italy). Animals were housed with a 12-h light-dark cycle with ad libitum access to food and water. Animal care and experiments were carried out in accordance with the guidelines of the Italian Ministry of Health for Animal care (DM 116/1992).
Retinal ischemia was induced in adult rats by acutely increasing the IOP according to the method previously reported. and laid on a heating pad to maintain the body temperature at 371C. Topical anesthesia was induced by 0.4% oxibuprocain eye drops (Novesina, Novartis, Varese, Italy). A 27-gauge infusion needle, connected to a 500-ml bottle of sterile saline, was inserted in the anterior chamber of the right eye, and the saline container was elevated to produce an IOP of 120 mm Hg for 50 min. Retinal ischemia was confirmed by whitening of the fundus. For each animal, the left eye was used as non-ischemic control.
Body temperature was monitored before and after ischemia, and animals with a value lower than 35.51C were excluded. Animals were killed by cervical dislocation at the end of the ischemia or at 1, 6, 24 h or 7 days after ischemia. Eyes were removed, retinas quickly dissected, snap frozen in liquid nitrogen and stored at À801C until use. Time points were chosen based on our previous study. 15 Cell culture and treatments. The rat RGC line (RGC-5), established by transforming rat postnatal day 1 retinal cells with the 2C E1A virus, 40 was purchased from the American Type Culture Collection (Manassas, VA, USA). Cells were cultured in high-glucose Dulbecco's Modified Eagle's Medium with L-glutamine (Invitrogen, Carlsbad, CA, USA), supplemented with 10% fetal bovine serum (FBS; Invitrogen) and were grown at 371C in a humidified atmosphere with 5% CO 2 . Depending on the experiment performed, cells were seeded in 6-or 96-well plates, in 10 cm petri dishes or coverslip and grown for 24 h before treatments.
Cells were subjected to starvation in serum-free media for 24 h. Where indicated, Bafilomycin A1 (BafA1; 100 nM; Sigma-Aldrich, Milan, Italy) or 3-MA (10 mM; Sigma-Aldrich) were added to the medium and maintained during the starvation period. Control cells were treated with the corresponding amount of vehicles.
Intravitreal administrations. The NMDA antagonist MK801 (SigmaAldrich) was dissolved in sterile phosphate-buffered saline (PBS) A stock solution of the calpain inhibitors MDL28170 or SJA6017 (Calbiochem, La Jolla, CA, USA) was prepared in 100% dimethylsulfoxide (DMSO) at the concentration of 10 and 20 mM, respectively. The stocks were subsequently diluted to the final concentration using sterile PBS.
Intravitreal injection was performed by puncturing the eye with a 23-gauge needle at the cornea-sclera junction and the drugs administered with a 5-ml Hamilton syringe (Bonaduz, GR, Switzerland). MK801 (50 nmol/5 ml/eye), 15 MDL28170 (0.5-1.0 mM/3 ml/eye), SJA6017 (0.5-1.0 mM/3 ml/eye) or control solution (2.5-5% DMSO in PBS/3 ml/eye) was administered 5 min before and at the end of the ischemia. The duration of the injection was 3 min in all instances. At the indicated time points, animals were killed, and subjects with visible lens damage or vitreous hemorrhage were excluded from the study.
